362 related articles for article (PubMed ID: 29196555)
21. Activation of the RalGEF/Ral pathway promotes prostate cancer metastasis to bone.
Yin J; Pollock C; Tracy K; Chock M; Martin P; Oberst M; Kelly K
Mol Cell Biol; 2007 Nov; 27(21):7538-50. PubMed ID: 17709381
[TBL] [Abstract][Full Text] [Related]
22. Ral activation promotes melanomagenesis.
Zipfel PA; Brady DC; Kashatus DF; Ancrile BD; Tyler DS; Counter CM
Oncogene; 2010 Aug; 29(34):4859-64. PubMed ID: 20562921
[TBL] [Abstract][Full Text] [Related]
23. Activation of the Ral and phosphatidylinositol 3' kinase signaling pathways by the ras-related protein TC21.
Rosário M; Paterson HF; Marshall CJ
Mol Cell Biol; 2001 Jun; 21(11):3750-62. PubMed ID: 11340168
[TBL] [Abstract][Full Text] [Related]
24. Expression profiling of Ral-depleted bladder cancer cells identifies RREB-1 as a novel transcriptional Ral effector.
Oxford G; Smith SC; Hampton G; Theodorescu D
Oncogene; 2007 Nov; 26(50):7143-52. PubMed ID: 17496927
[TBL] [Abstract][Full Text] [Related]
25. Ral small GTPase signaling and oncogenesis: More than just 15minutes of fame.
Gentry LR; Martin TD; Reiner DJ; Der CJ
Biochim Biophys Acta; 2014 Dec; 1843(12):2976-2988. PubMed ID: 25219551
[TBL] [Abstract][Full Text] [Related]
26. The small G-protein RalA promotes progression and metastasis of triple-negative breast cancer.
Thies KA; Cole MW; Schafer RE; Spehar JM; Richardson DS; Steck SA; Das M; Lian AW; Ray A; Shakya R; Knoblaugh SE; Timmers CD; Ostrowski MC; Chakravarti A; Sizemore GM; Sizemore ST
Breast Cancer Res; 2021 Jun; 23(1):65. PubMed ID: 34118960
[TBL] [Abstract][Full Text] [Related]
27. Advances in targeting the Ras/Raf/MEK/Erk mitogen-activated protein kinase cascade with MEK inhibitors for cancer therapy.
Friday BB; Adjei AA
Clin Cancer Res; 2008 Jan; 14(2):342-6. PubMed ID: 18223206
[TBL] [Abstract][Full Text] [Related]
28. Thermodynamic mapping of effector protein interfaces with RalA and RalB.
Campbell LJ; Peppa M; Crabtree MD; Shafiq A; McGough NF; Mott HR; Owen D
Biochemistry; 2015 Feb; 54(6):1380-9. PubMed ID: 25621740
[TBL] [Abstract][Full Text] [Related]
29. Divergent roles for RalA and RalB in malignant growth of human pancreatic carcinoma cells.
Lim KH; O'Hayer K; Adam SJ; Kendall SD; Campbell PM; Der CJ; Counter CM
Curr Biol; 2006 Dec; 16(24):2385-94. PubMed ID: 17174914
[TBL] [Abstract][Full Text] [Related]
30. Small molecule inhibitors of RAS proteins with oncogenic mutations.
Orgován Z; Keserű GM
Cancer Metastasis Rev; 2020 Dec; 39(4):1107-1126. PubMed ID: 32770300
[TBL] [Abstract][Full Text] [Related]
31. Ral-GTPases mediate a distinct downstream signaling pathway from Ras that facilitates cellular transformation.
Urano T; Emkey R; Feig LA
EMBO J; 1996 Feb; 15(4):810-6. PubMed ID: 8631302
[TBL] [Abstract][Full Text] [Related]
32. Geranylgeranyltransferase I inhibitors target RalB to inhibit anchorage-dependent growth and induce apoptosis and RalA to inhibit anchorage-independent growth.
Falsetti SC; Wang DA; Peng H; Carrico D; Cox AD; Der CJ; Hamilton AD; Sebti SM
Mol Cell Biol; 2007 Nov; 27(22):8003-14. PubMed ID: 17875936
[TBL] [Abstract][Full Text] [Related]
33. Ral GTPase down-regulation stabilizes and reactivates p53 to inhibit malignant transformation.
Tecleab A; Zhang X; Sebti SM
J Biol Chem; 2014 Nov; 289(45):31296-309. PubMed ID: 25210032
[TBL] [Abstract][Full Text] [Related]
34. Sec5 and Exo84 foster oncogenic ras-mediated tumorigenesis.
Issaq SH; Lim KH; Counter CM
Mol Cancer Res; 2010 Feb; 8(2):223-31. PubMed ID: 20145037
[TBL] [Abstract][Full Text] [Related]
35. Ral GTPases in tumorigenesis: emerging from the shadows.
Kashatus DF
Exp Cell Res; 2013 Sep; 319(15):2337-42. PubMed ID: 23830877
[TBL] [Abstract][Full Text] [Related]
36. The B cell antigen receptor controls AP-1 and NFAT activity through Ras-mediated activation of Ral.
de Gorter DJ; Vos JC; Pals ST; Spaargaren M
J Immunol; 2007 Feb; 178(3):1405-14. PubMed ID: 17237388
[TBL] [Abstract][Full Text] [Related]
37. RalA is overactivated in medulloblastoma.
Ginn KF; Fangman B; Terai K; Wise A; Ziazadeh D; Shah K; Gartrell R; Ricke B; Kimura K; Mathur S; Borrego-Diaz E; Farassati F
J Neurooncol; 2016 Oct; 130(1):99-110. PubMed ID: 27566179
[TBL] [Abstract][Full Text] [Related]
38. RALB provides critical survival signals downstream of Ras in acute myeloid leukemia.
Eckfeldt CE; Pomeroy EJ; Lee RD; Hazen KS; Lee LA; Moriarity BS; Largaespada DA
Oncotarget; 2016 Oct; 7(40):65147-65156. PubMed ID: 27556501
[TBL] [Abstract][Full Text] [Related]
39. RAL GTPases mediate EGFR-driven intestinal stem cell proliferation and tumourigenesis.
Nászai M; Bellec K; Yu Y; Román-Fernández A; Sandilands E; Johansson J; Campbell AD; Norman JC; Sansom OJ; Bryant DM; Cordero JB
Elife; 2021 Jun; 10():. PubMed ID: 34096503
[TBL] [Abstract][Full Text] [Related]
40. Ral GTPases in Schwann cells promote radial axonal sorting in the peripheral nervous system.
Ommer A; Figlia G; Pereira JA; Datwyler AL; Gerber J; DeGeer J; Lalli G; Suter U
J Cell Biol; 2019 Jul; 218(7):2350-2369. PubMed ID: 31201267
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
